Transcode Therapeutics Inc. (RNAZ)
Market Closed
17 Dec, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
8. 46
-0.64
-7.08%
$
8.52M Market Cap
- P/E Ratio
0% Div Yield
10,225 Volume
-2.14 Eps
$ 9.11
Previous Close Day Range
8.26 9.16
Year Range
6.15 468.44
Want to track RNAZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| RNAZ Transcode Therapeutics Inc. 17 Nov 2025 | | - | - |
| RNAZ Transcode Therapeutics Inc. 13 Nov 2025 | | - | - |
| RNAZ Transcode Therapeutics Inc. 13 Aug 2025 | | - | - |
| RNAZ Transcode Therapeutics Inc. 19 May 2025 | | - | - |
| RNAZ Transcode Therapeutics Inc. 18 Nov 2024 | | - | - |
| RNAZ Transcode Therapeutics Inc. 16 Aug 2024 | | - | - |
| RNAZ Transcode Therapeutics Inc. 29 Mar 2024 | | - | - |
| RNAZ Transcode Therapeutics Inc. 15 Nov 2023 | | - | - |
RNAZ Earnings Reports FAQ
What is the earnings per share (EPS) for RNAZ?
The current EPS is -2.14.
What is the company's earnings growth rate?
Transcode Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Transcode Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Transcode Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RNAZ at this time, as Transcode Therapeutics Inc has no recent EPS data to calculate it.
